Abstract
Diabetes poses great challenge to the world’s health care system. Its worldwide prevalence was estimated at 366 million in 2011 of these, 183 million people were believed to be unaware of their condition. If no measures taken, the prevalence is projected to rise to 552 million people by 2030, representing around 10% of the global adult population. The aim of present study was designed to examine the potential anti-hyperlipidaemic and antihyperlipidemia efficacy of the aqueous extract from Aloe vera leaf gel in alloxan-induced diabetic mice. The animals were divided into three groups of normal mice; alloxan-induced diabetic mice and diabetic mice treated with 300mg/kg b.w of the aqueous leaf extract, respectively. Treatment was via the oral route for 21days. Various biochemical parameters, including lipid profile and serum glucose were decreased as well as HDL-C increased. Statistical analysis were done by one way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. These results demonstrate the anti-diabetic and antihyperlipidaemic activities of Aloe vera leaf extract in diabetic mice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
